Dr Celine Risterucci
PhD, Global Clinical Development Director at Novartis (WP 2)
Dr Celine Risterucci has been involved in 5 Malaria Clinical Trials as Clinical Development Director at Novartis over the past 5 years. In the PAMAfrica consortium she will be involved in a Ph2/3 Clinical Trial (CALINA) evaluating a new formulation of artemether-lumefantrine dispersible tablet in infants and neonates with acute uncomplicated P. falciparum malaria. She has published, as author or co-author, 27 original research papers in peer-reviewed journals.